FIELD: medicine. SUBSTANCE: method involves determining transforming growth factor β1 blood serum concentration before and after surgical intervention and in early postoperative period. The value remaining unchanged or lowering in early postoperative period, excessive cicatrix formation is to be predicted. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING COURSE OF REPARATIVE PROCESSES IN OUTFLOW TRACTS OF INTRAOCULAR FLUID IN PATIENTS WITH OPEN-ANGLE GLAUCOMA AFTER NON-PENETRATING DEEP SCLERECTOMY | 2020 |
|
RU2749121C1 |
| METHOD OF PREDICTING EXCESS SCARRING AFTER ANTIGLAUCOMATOUS OPERATIONS IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2009 |
|
RU2402770C1 |
| METHOD OF PROGNOSTICATION OF EXCESSIVE CICATRIZATION AFTER ANTIGLAUCOMATOUS OPERATION | 1998 |
|
RU2140647C1 |
| METHOD FOR PROPHYLAXIS OF EXCESSIVE SCARING AFTER ANTI-GLAUCOMATOUS OPERATIONS | 2004 |
|
RU2281117C2 |
| METHOD FOR SURGICAL TREATMENT OF GLAUCOMA | 2004 |
|
RU2281073C2 |
| METHOD FOR SURGICAL TREATMENT OF OPEN-ANGLE GLAUCOMA | 2016 |
|
RU2630884C1 |
| METHOD FOR PREDICTING COMPLICATIONS AFTER ANTIGLAUCOMATOUS OPERATION IN CASE OF INBORN GLAUCOMA | 2003 |
|
RU2242003C1 |
| IMMUNOREGULATING PROPERTY OF NATURAL CYTOKINES COMPLEX IN PROPHYLAXIS OF DEVELOPMENT OF CATARACT AFTER ANTIGLAUCOMATOUS OPERATIONS | 2000 |
|
RU2180853C1 |
| METHOD FOR SURGICAL MANAGEMENT OF CONGENITAL GLAUCOMA IN CHILDREN | 2023 |
|
RU2825183C1 |
| METHOD FOR TREATING GLAUCOMA | 1998 |
|
RU2161024C2 |
